|
|
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 14, Issue 2, 545-555, February 2003
during Bone
Morphogenetic Protein 2-induced Adipogenesis


and
*Departments of Biochemistry and
Bone morphogenetic protein 2 (BMP2) promotes the
differentiation of undifferentiated mesenchymal cells into adipocytes.
To investigate the molecular mechanisms that regulate this
differentiation process, we studied the relationship between BMP2
signaling and peroxisome proliferator-activating receptor
Removable Prothodontics, Osaka University
Graduate School/Faculty of Dentistry, Osaka 565-0871, Japan
(PPAR
)
during adipogenesis of mesenchymal cells by using pluripotent
mesenchymal cell line C3H10T1/2. In C3H10T1/2 cells, BMP2 induced
expression of PPAR
along with adipogenesis. Overexpression of Smad6,
a natural antagonist for Smad1, blocked PPAR
expression and
adipocytic differentiation induced by BMP2. Overexpression of
dominant-negative PPAR
also diminished adipocytic differentiation of
C3H10T1/2 cells, suggesting the central role of PPAR
in BMP2-induced
adipocytic differentiation. Specific inhibitors for p38 kinase
inhibited BMP2-induced adipocytic differentiation and transcriptional
activation of PPAR
, whereas overexpression of Smad6 had no effect on
transcriptional activity of PPAR
. Furthermore, activation of p38
kinase by overexpression of TAK1 and TAB1, without affecting PPAR
expression, led the up-regulation of transcriptional activity of
PPAR
. These results suggest that both Smad and p38 kinase signaling
are concomitantly activated and responsible for BMP2-induced adipocytic
differentiation by inducing and up-regulating PPAR
, respectively.
Thus, BMP2 controls adipocytic differentiation by using two distinct
signaling pathways that play differential roles in this process in
C3H10T1/2 cells.
Corresponding author. E-mail address:
rikonisi{at}dent.osaka-u.ac.jp.
This article has been cited by other articles:
![]() |
F. McGuigan, E. Larzenius, M. Callreus, P. Gerdhem, H. Luthman, and K. Akesson Variation in the bone morphogenetic protein-2 gene: effects on fat and lean body mass in young and elderly women Eur. J. Endocrinol., May 1, 2008; 158(5): 661 - 668. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ptasinska, S. Wang, J. Zhang, R. A. Wesley, and R. L. Danner Nitric oxide activation of peroxisome proliferator-activated receptor gamma through a p38 MAPK signaling pathway FASEB J, March 1, 2007; 21(3): 950 - 961. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pache, C. Schafer, S. Wiesemann, E. Springer, M. Liebau, H. C. Reinhardt, C. August, H. Pavenstadt, and M. J. Bek Upregulation of Id-1 via BMP-2 receptors induces reactive oxygen species in podocytes Am J Physiol Renal Physiol, September 1, 2006; 291(3): F654 - F662. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Ikeda, R. Nishimura, T. Matsubara, K. Hata, S. V. Reddy, and T. Yoneda Activation of NFAT Signal In Vivo Leads to Osteopenia Associated with Increased Osteoclastogenesis and Bone-Resorbing Activity J. Immunol., August 15, 2006; 177(4): 2384 - 2390. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Gao, Q. He, B. Peng, P. J. Chiao, and J. Ye Regulation of Nuclear Translocation of HDAC3 by I{kappa}B{alpha} Is Required for Tumor Necrosis Factor Inhibition of Peroxisome Proliferator-activated Receptor {gamma} Function J. Biol. Chem., February 17, 2006; 281(7): 4540 - 4547. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Aouadi, K. Laurent, M. Prot, Y. Le Marchand-Brustel, B. Binetruy, and F. Bost Inhibition of p38MAPK Increases Adipogenesis From Embryonic to Adult Stages Diabetes, February 1, 2006; 55(2): 281 - 289. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. T. Schaiff, I. Bildirici, M. Cheong, P. L. Chern, D. M. Nelson, and Y. Sadovsky Peroxisome Proliferator-Activated Receptor-{gamma} and Retinoid X Receptor Signaling Regulate Fatty Acid Uptake by Primary Human Placental Trophoblasts J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4267 - 4275. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Burgess, L. E. Daugherty, T. H. Thatcher, H. F. Lakatos, D. M. Ray, M. Redonnet, R. P. Phipps, and P. J. Sime PPAR{gamma} agonists inhibit TGF-{beta} induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis Am J Physiol Lung Cell Mol Physiol, June 1, 2005; 288(6): L1146 - L1153. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Ichida, R. Nishimura, K. Hata, T. Matsubara, F. Ikeda, K. Hisada, H. Yatani, X. Cao, T. Komori, A. Yamaguchi, et al. Reciprocal Roles of Msx2 in Regulation of Osteoblast and Adipocyte Differentiation J. Biol. Chem., August 6, 2004; 279(32): 34015 - 34022. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Hu, D. Wasserman, S. Hartwig, and N. D. Rosenblum p38MAPK Acts in the BMP7-dependent Stimulatory Pathway during Epithelial Cell Morphogenesis and Is Regulated by Smad1 J. Biol. Chem., March 26, 2004; 279(13): 12051 - 12059. [Abstract] [Full Text] [PDF] |
||||